Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer

Fig. 2

Comparison of mutation and neoantigen burden of chemotherapy-treated and untreated samples. Mutations (upper left), neoantigens (upper right), and expressed neoantigens by count (lower left) and as a percent of total neoantigens (lower right) are shown for primary/untreated samples (blue; solid tumor n=75, ascites n=4), primary/treated samples (green; solid tumor n=5), and relapse/treated samples (red; solid tumor n=6 samples from 3 patients, ascites n=24 samples from 21 patients). The shaded boxes indicate the interquartile region and the median line; multiple samples of the same type from the same patient have been reweighted so that each patient contributes equally. Points indicate individual samples

Back to article page